Risk factors and visual outcome of Non-Arteritic Ischemic Optic Neuropathy (NAION): Experience of a tertiary center in Kuwait

Affiliations


Abstract

Background: Non-arteritic ischemic optic neuropathy (NAION) is the most common acute optic neuropathy over the age of 50 years. NAION is commonly associated with systemic vascular risk factors (diabetes, hypertension, hyperlipidemia) and small cup-to-disc-ratio. We have assessed the prevalence risk factors of NAION and the visual outcome in patients referred to a tertiary ophthalmology center in Kuwait.

Materials and methods: A retrospective review of new cases of NAION presenting within 2 weeks of onset were included and baseline clinical and demographics characteristic were determined. The prevalence of risk factors and the visual outcome (change in logMAR visual acuity, mean deviation of visual field) was compared between young NAION patients (below 50 years of age) and older NAION patients (over 50 years of age). The odds ratio of a final favorable visual outcome (visual acuity 20/40 or better) by age category was determined.

Results: Seventy-eight eyes of 78 patients with recent onset NAION were included in the study. The most prevalent risk factors for NAION in our subjects were diabetes (64.1%), small cup-to-disc ratio (61.5%), hyperlipidemia (51.3%) and hypertension (38.5%). Young NAION patients had better final logMAR visual acuity (0.55 +- 0.57) then older NAION patients (0.9 +- 0.73), (p = 0.03). Furthermore, young NAION patients were 2.8 times more likely to have a final visual acuity of 20/40 or better than older NAION patients, odds ratio (OR), 2.87; 95% confidence interval (CI), 1.12-7.40, Chi-square p-value = 0.03).

Conclusion: There is a high prevalence of systemic vascular risk factors and small cup-to-disc ratio in NAION patients referred to our center across different age groups (below and above 50 years). Patients below the age of 50 years with NAION are more likely to have a final visual acuity of 20/40 or better than NAION patients above the age of 50 years.

Conflict of interest statement

The authors have declared that no competing interests exist.


Figures


Similar articles

[Optic nerve morphology and vessel density in eyes with different phases of non-arteritic anterior ischemic optic neuropathy].

Wang YH, Ma J, Gan LY, Zhang X, Wang XQ, Chou YY, Wang XJ, Sun ZZ, Tao ZY, Zhong Y.Zhonghua Yan Ke Za Zhi. 2019 Sep 11;55(9):677-686. doi: 10.3760/cma.j.issn.0412-4081.2019.09.010.PMID: 31495153 Chinese.

Comparison of Visual Outcomes of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients with and without Diabetes Mellitus.

Sharma S, Kwan S, Fallano KA, Wang J, Miller NR, Subramanian PS.Ophthalmology. 2017 Apr;124(4):450-455. doi: 10.1016/j.ophtha.2016.11.029. Epub 2016 Dec 22.PMID: 28017420

Non-Arteritic Ischemic Optic Neuropathy Following COVID-19 Vaccination in Korea: A Case Series.

Moon Y, Jung JH, Shin HJ, Choi DG, Park KA, Jeon H, Lee BJ, Kim SJ, Oh SY, Ahn H, Chung SA, Kim US, Lee HJ, Lee JY, Choi YJ; Korean Neuro-Ophthalmology Society.J Korean Med Sci. 2023 Mar 27;38(12):e95. doi: 10.3346/jkms.2023.38.e95.PMID: 36974402 Free PMC article.

Visual outcome following bilateral non-arteritic anterior ischemic optic neuropathy: a systematic review and meta-analysis.

Keren S, Zanolli M, Dotan G.BMC Ophthalmol. 2017 Aug 24;17(1):155. doi: 10.1186/s12886-017-0543-y.PMID: 28836961 Free PMC article. Review.

Cardiometabolic factors and risk of non-arteritic anterior ischemic optic neuropathy: a systematic review and meta-analysis.

Chatziralli IP, Kazantzis D, Chatzirallis AP, Machairoudia G, Papageorgiou EG, Theodossiadis GP, Psaltopoulou T, Theodossiadis PG, Sergentanis TN.Graefes Arch Clin Exp Ophthalmol. 2022 May;260(5):1445-1456. doi: 10.1007/s00417-021-05522-4. Epub 2022 Jan 24.PMID: 35067769 Review.


Cited by

The Risk of Non-arteritic Ischemic Optic Neuropathy Post-intravitreal Bevacizumab Injection.

Fugara NA, Shawareb ZA, Rakkad NK, Barhoum ML, Shawareb BA, Al-Madani MM, Al-Madani MV.Cureus. 2022 Oct 11;14(10):e30185. doi: 10.7759/cureus.30185. eCollection 2022 Oct.PMID: 36397890 Free PMC article.

COVID-19 Vaccine-Associated Optic Neuropathy: A Systematic Review of 45 Patients.

Elnahry AG, Al-Nawaflh MY, Gamal Eldin AA, Solyman O, Sallam AB, Phillips PH, Elhusseiny AM.Vaccines (Basel). 2022 Oct 20;10(10):1758. doi: 10.3390/vaccines10101758.PMID: 36298623 Free PMC article. Review.

Factors Associated With Visual Acuity in Non-arteritic Ischemic Optic Neuropathy Patients: A Five-Year Cross-Sectional Study.

Kemchoknatee P, Singhakul C, Tangon D, Srisombut T.Cureus. 2022 Sep 14;14(9):e29156. doi: 10.7759/cureus.29156. eCollection 2022 Sep.PMID: 36259038 Free PMC article.

Risk of Ocular Adverse Events With Taxane-Based Chemotherapy.

Sodhi M, Yeung SN, Maberley D, Mikelberg F, Etminan M.JAMA Ophthalmol. 2022 Sep 1;140(9):880-884. doi: 10.1001/jamaophthalmol.2022.3026.PMID: 35951320

The Protective Effects of n-Butylidenephthalide on Retinal Ganglion Cells during Ischemic Injury.

Chou YY, Chien JY, Ciou JW, Huang SP.Int J Mol Sci. 2022 Feb 14;23(4):2095. doi: 10.3390/ijms23042095.PMID: 35216208 Free PMC article.


KMEL References


References

  1.  
    1. Yee RD, Selky AK, Purvin VA. Outcomes of optic nerve sheath decompression for nonarteritic ischemic optic neuropathy. J Neuroophthalmol. 1994;14(2):70–6. - PubMed
  2.  
    1. Beri M, Klugman MR, Kohler JA, Hayreh SS. Anterior ischemic optic neuropathy. VII. Incidence of bilaterality and various influencing factors. Ophthalmology. 1987;94(8):1020–8. 10.1016/s0161-6420(87)33350-0 - DOI - PubMed
  3.  
    1. Jacobson DM, Vierkant RA, Belongia EA. Nonarteritic anterior ischemic optic neuropathy. A case-control study of potential risk factors. Arch Ophthalmol. 1997;115(11):1403–7. 10.1001/archopht.1997.01100160573008 - DOI - PubMed
  4.  
    1. Tesser RA, Niendorf ER, Levin LA. The morphology of an infarct in nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2003;110(10):2031–5. 10.1016/S0161-6420(03)00804-2 - DOI - PubMed
  5.  
    1. Hayreh SS, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome. Ophthalmology. 2008;115(2):298–305 e2. 10.1016/j.ophtha.2007.05.027 - DOI - PMC - PubMed
  6.  
    1. Sharma S, Kwan S, Fallano KA, Wang J, Miller NR, Subramanian PS. Comparison of Visual Outcomes of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients with and without Diabetes Mellitus. Ophthalmology. 2017;124(4):450–5. 10.1016/j.ophtha.2016.11.029 - DOI - PubMed
  7.  
    1. Deramo VA, Sergott RC, Augsburger JJ, Foroozan R, Savino PJ, Leone A. Ischemic optic neuropathy as the first manifestation of elevated cholesterol levels in young patients. Ophthalmology. 2003;110(5):1041–6; discussion 6. 10.1016/S0161-6420(03)00079-4 - DOI - PubMed
  8.  
    1. Preechawat P, Bruce BB, Newman NJ, Biousse V. Anterior ischemic optic neuropathy in patients younger than 50 years. Am J Ophthalmol. 2007;144(6):953–60. 10.1016/j.ajo.2007.07.031 - DOI - PubMed
  9.  
    1. Boghen DR, Glaser JS. Ischaemic optic neuropathy. The clinical profile and history. Brain. 1975;98(4):689–708. 10.1093/brain/98.4.689 - DOI - PubMed
  10.  
    1. Sawle GV, James CB, Russell RW. The natural history of non-arteritic anterior ischaemic optic neuropathy. J Neurol Neurosurg Psychiatry. 1990;53(10):830–3. 10.1136/jnnp.53.10.830 - DOI - PMC - PubMed
  11.  
    1. Alarouj M, Bennakhi A, Alnesef Y, Sharifi M, Elkum N. Diabetes and associated cardiovascular risk factors in the State of Kuwait: the first national survey. Int J Clin Pract. 2013;67(1):89–96. 10.1111/ijcp.12064 - DOI - PubMed
  12.  
    1. Hayreh SS, Jonas JB, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy and tobacco smoking. Ophthalmology. 2007;114(4):804–9. 10.1016/j.ophtha.2006.07.062 - DOI - PubMed
  13.  
    1. Sun MH, Liao YJ. Structure-Function Analysis of Nonarteritic Anterior Ischemic Optic Neuropathy and Age-Related Differences in Outcome. J Neuroophthalmol. 2017;37(3):258–64. 10.1097/WNO.0000000000000521 - DOI - PubMed
  14.  
    1. Palombi K, Renard E, Levy P, Chiquet C, Deschaux C, Romanet JP, et al. Non-arteritic anterior ischaemic optic neuropathy is nearly systematically associated with obstructive sleep apnoea. Br J Ophthalmol. 2006;90(7):879–82. 10.1136/bjo.2005.087452 - DOI - PMC - PubMed
  15.  
    1. Beck RW, Savino PJ, Repka MX, Schatz NJ, Sergott RC. Optic disc structure in anterior ischemic optic neuropathy. Ophthalmology. 1984;91(11):1334–7. 10.1016/s0161-6420(84)34146-x - DOI - PubMed
  16.  
    1. Beck RW, Savino PJ, Repka MX, Schatz NJ, Sergott RC. Structural factors in the pathogenesis of ischemic optic neuropathy. Am J Ophthalmol. 1984;98(5):649–50. 10.1016/0002-9394(84)90276-9 - DOI - PubMed
  17.  
    1. Biousse V, Newman NJ. Ischemic Optic Neuropathies. N Engl J Med. 2015;372(25):2428–36. 10.1056/NEJMra1413352 - DOI - PubMed
  18.  
    1. Borchert M, Lessell S. Progressive and recurrent nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1988;106(4):443–9. 10.1016/0002-9394(88)90881-1 - DOI - PubMed
  19.  
    1. Hamann S, Malmqvist L, Wegener M, Fard MA, Biousse V, Bursztyn L, et al. Young Adults With Anterior Ischemic Optic Neuropathy: A Multicenter Optic Disc Drusen Study. Am J Ophthalmol. 2020;217:174–81. 10.1016/j.ajo.2020.03.052 - DOI - PubMed